Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-... von Hurvitz, Sara, Singh, Rashi, Adams, Brad, Taguchi, Julie A., Chan, David, Dichmann, Robert A., Castrellon, Aurelio, Hu, Eddie, Berkowitz, Jonathan, Mani, Aruna, DiCarlo, Brian, Callahan, Rena, Smalberg, Ira, Wang, Xiaoyan, Meglar, Ivana, Martinez, Diego, Hobbs, Evthokia, Slamon, Dennis J.

Volltext

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial von Coiffier, Bertrand, Prof, Osmanov, Evgenii A, Prof, Hong, Xiaonan, Prof, Scheliga, Adriana, MD, Mayer, Jiri, Prof, Offner, Fritz, Prof, Rule, Simon, MD, Teixeira, Adriana, MD, Walewski, Jan, Prof, de Vos, Sven, MD, Crump, Michael, Prof, Shpilberg, Ofer, Prof, Esseltine, Dixie-Lee, MD, Zhu, Eugene, PhD, Enny, Christopher, BS, Theocharous, Panteli, PhD, van de Velde, Helgi, MD, Elsayed, Yusri A, MD, Zinzani, Pier Luigi, Prof

Volltext

nab -Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC von Langer, Corey J, Kim, Edward S, Anderson, Eric C, Jotte, Robert M, Modiano, Manuel, Haggstrom, Daniel E, Socoteanu, Matei P, Smith, David A, Dakhil, Christopher, Konduri, Kartik, Berry, Tymara, Ong, Teng J, Sanford, Alexandra, Amiri, Katayoun, Goldman, Jonathan W, Weiss, Jared

Volltext

Genome of the Western Clawed Frog Xenopus tropicalis von Hellsten, Uffe, Harland, Richard M, Gilchrist, Michael J, Hendrix, David, Jurka, Jerzy, Kapitonov, Vladimir, Ovcharenko, Ivan, Putnam, Nicholas H, Shu, Shengqiang, Taher, Leila, Blitz, Ira L, Blumberg, Bruce, Dichmann, Darwin S, Dubchak, Inna, Amaya, Enrique, Detter, John C, Fletcher, Russell, Gerhard, Daniela S, Goodstein, David, Graves, Tina, Grigoriev, Igor V, Grimwood, Jane, Kawashima, Takeshi, Lindquist, Erika, Lucas, Susan M, Mead, Paul E, Mitros, Therese, Ogino, Hajime, Ohta, Yuko, Poliakov, Alexander V, Pollet, Nicolas, Robert, Jacques, Salamov, Asaf, Sater, Amy K, Schmutz, Jeremy, Terry, Astrid, Vize, Peter D, Warren, Wesley C, Wells, Dan, Wills, Andrea, Wilson, Richard K, Zimmerman, Lyle B, Zorn, Aaron M, Grainger, Robert, Grammer, Timothy, Khokha, Mustafa K, Richardson, Paul M, Rokhsar, Daniel S

Volltext

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07) von Hurvitz, Sara A., Caswell-Jin, Jennifer L., McNamara, Katherine L., Zoeller, Jason J., Bean, Gregory R., Dichmann, Robert, Perez, Alejandra, Patel, Ravindranath, Zehngebot, Lee, Allen, Heather, Bosserman, Linda, DiCarlo, Brian, Kennedy, April, Giuliano, Armando, Calfa, Carmen, Molthrop, David, Mani, Aruna, Chen, Hsiao-Wang, Dering, Judy, Adams, Brad, Kotler, Eran, Press, Michael F., Brugge, Joan S., Curtis, Christina, Slamon, Dennis J.

Volltext

Genome evolution in the allotetraploid frog Xenopus laevis von Session, Adam M., Uno, Yoshinobu, Kwon, Taejoon, Chapman, Jarrod A., Toyoda, Atsushi, Takahashi, Shuji, Fukui, Akimasa, Hikosaka, Akira, Suzuki, Atsushi, Kondo, Mariko, van Heeringen, Simon J., Quigley, Ian, Heinz, Sven, Ogino, Hajime, Ochi, Haruki, Hellsten, Uffe, Lyons, Jessica B., Simakov, Oleg, Putnam, Nicholas, Stites, Jonathan, Kuroki, Yoko, Tanaka, Toshiaki, Michiue, Tatsuo, Watanabe, Minoru, Bogdanovic, Ozren, Lister, Ryan, Georgiou, Georgios, Paranjpe, Sarita S., van Kruijsbergen, Ila, Shu, Shengquiang, Carlson, Joseph, Kinoshita, Tsutomu, Ohta, Yuko, Mawaribuchi, Shuuji, Jenkins, Jerry, Grimwood, Jane, Schmutz, Jeremy, Mitros, Therese, Mozaffari, Sahar V., Suzuki, Yutaka, Haramoto, Yoshikazu, Yamamoto, Takamasa S., Takagi, Chiyo, Heald, Rebecca, Miller, Kelly, Haudenschild, Christian, Kitzman, Jacob, Nakayama, Takuya, Izutsu, Yumi, Robert, Jacques, Fortriede, Joshua, Burns, Kevin, Lotay, Vaneet, Karimi, Kamran, Yasuoka, Yuuri, Dichmann, Darwin S., Flajnik, Martin F., Houston, Douglas W., Shendure, Jay, DuPasquier, Louis, Vize, Peter D., Zorn, Aaron M., Ito, Michihiko, Marcotte, Edward M., Wallingford, John B., Ito, Yuzuru, Asashima, Makoto, Ueno, Naoto, Matsuda, Yoichi, Veenstra, Gert Jan C., Fujiyama, Asao, Harland, Richard M., Taira, Masanori, Rokhsar, Daniel S.

Volltext

Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, place... von Fuchs, Charles S, Di Bartolomeo, Maria, Lonardi, Sara, Van Cutsem, Eric, Ilson, David H, Alsina, Maria, Chau, Ian, Lacy, Jill, Ducreux, Michel, Mendez, Guillermo Ariel, Alavez, Alejandro Molina, Takahari, Daisuke, Gorbounova, Vera, Wainberg, Zev A, Hegewisch-Becker, Susanna, Ferry, David, Lin, Ji, Das, Mayukh, Shah, Manish A, Karaseva, Nina A., Csoszi, Tibor, De Vita, Ferdinando, Sugimoto, Naotoshi, Kocsis, Judit, Csilla, Andràs, Bodoky, Gyorgy, Protsenko, Svetlana, Madi, Ayman, Wojcik, Elzbieta, Brenner, Baruch, Sarosiek, Tomasz, Peltola, Katriina Johanna, Bono, Peter, Aprile, Giuseppe, Falcone, Alfredo, Di Costanzo, Francesco, García Alfonso, Pilar, Senellart, Hélène, Petty, Russell, Samuel, Leslie, Hussein, Maen Abdelkarim, Won, Elizabeth, Bendell, Johanna Chock, Lorenzen, Sylvie, Melichar, Bohuslav, Pezet, Denis, Phelip, Jean-Marc, Kaen, Diego Lucas, Madhusudan, Srinivasan, Barone, Carlo, Fein, Luis Enrique, Gomez Villanueva, Angel, Prausova, Jana, Vidal Barrull, Joana, Yilmaz, Mette Karen Nytoft, DiCarlo, Brian Anthony, Geboes, Karen, Geva, Ravit, Kadowaki, Shigenori, Machida, Nozomu, Ramirez Godinez, Francisco Javier, Ruzsa, Agnes, Ford, Hugo, Lawler, William E., Petera, Jiri, Yamaguchi, Kensei, Hara, Hiroki, Beck, Joseph Thaddeus, Błasińska-Morawiec, Maria, Alcindor, Thierry, Bajaj, Madhuri, Berry, Scott, Dammrich, Daniel, Taieb, Julien, Ten Tije, A.J., Burkes, Ronald L., Cabanillas, Fernando, Firdaus, Irfan, Chua, Cynthia Coo, Hironaka, Shuichi, Hofheinz, Ralf-Dieter, Lim, Howard J., Nordsmark, Marianne, Verma, Udit, Wadsley, Jonathan, Yukisawa, Seigo, Pikiel, Joanna, Wojcik-Tomaszewska, Joanna, Brezden-Masley, Christine, Jang, Raymond Woo-Jun, Pribylova, Jana, Sakai, Daisuke, Bartoli, Maria Alejandra, Cats, A., Grootscholten, M.I., Dichmann, Robert Andrew, Hool, Hugo, Shaib, Walid, Tsuji, Akihito, Asmis, Timothy R.

Volltext

Abstract P4-07-01: Tumor expression and microenvironment in HER2-positive breast cancer before and on HER2-targeted therapy: Analysis of microarray expression data from the TRIO-US... von Caswell-Jin, Jennifer L., McNamara, Katherine L., Dering, Judy, Chen, Hsiao-Wang, Dichmann, Robert, Perez, Alejandra, Patel, Ravindranath, Kotler, Eran, Zoeller, Jason J., Brugge, Joan S., Press, Michael F., Slamon, Dennis J., Curtis, Christina, Hurvitz, Sara A.

Volltext

A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of idelalisib in combination with rituximab for previously treated indolent non-Hod... von Salles, Gilles A., Ervin, Thomas J., Dichmann, Robert, Ramchandren, Rod, Page, Ray D., Battini, Ramakrishna, Lawler, William E., Holes, Leanne, Adewoye, Adeboye H., De Vos, Sven

Volltext

A phase I/II study of carfilzomib (CFZ) as a replacement for bortezomib (BTZ) for multiple myeloma (MM) patients (Pts) progressing while receiving a BTZ-containing combination regi... von Berenson, James R., Yellin, Ori, Dichmann, Robert, Patel-Donnelly, Dipti, Boccia, Ralph V., Hilger, James D., Nassir, Youram, Swift, Regina A., Vescio, Robert A.

Volltext

Results of a phase I/II study (NCT01365559) of carfilzomib (CFZ) replacing bortezomib (BTZ) in BTZ-containing regimens for BTZ-treated patients (pts) with relapsed and refractory m... von Berenson, James R., Hilger, James D., Dichmann, Robert, Patel-Donnelly, Dipti, Boccia, Ralph V., Bessudo, Alberto, Stampleman, Laura, Gravenor, Donald, Eshaghian, Shahrooz, Chamras, Hilda, Nassir, Youram, Swift, Regina A., Vescio, Robert A.

Volltext

A Phase 1/2 Study of Carfilzomib As a Replacement for Bortezomib for Multiple Myeloma (MM) Patients (pts) Refractory to a Bortezomib-Containing Combination Regimen von Berenson, James R., Hilger, James D., Dichmann, Robert, Patel-Donnelly, Dipti, Boccia, Ralph V., Bessudo, Alberto, Stampleman, Laura V., Gravenor, Donald S., Eshaghian, Shahrooz, Nassir, Youram, Swift, Regina A., Vescio, Robert

Volltext